Lechenie sakharnogo diabeta 2 tipa ingibitorami dipeptidilpeptidazy-4
Type 2 diabetes is difficult to manage and multiple therapeutic approach are usually needed. Moreover, addition to the initial treatment of most currently available oral antidiabetic agents increases the risk of hypoglycaemia and causes a weight gain. Dipeptidyl peptidase-IV inhibitors improve glyca...
Format: | Article |
---|---|
Language: | English |
Published: |
Endocrinology Research Centre
2010-09-01
|
Series: | Ожирение и метаболизм |
Subjects: | |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/4976 |